Long-term efficacy of therapeutic drug monitoring-guided optimization of ustekinumab maintenance therapy for Crohn’s disease patients
Abstract Long-term remission in Crohn’s disease (CD) remains challenging. While ustekinumab effectively induces remission, strategies to enhance its maintenance efficacy are urgently needed. This study evaluated therapeutic drug monitoring (TDM)-guided ustekinumab optimization for sustained CD manag...
Saved in:
| Main Authors: | Haixia Ren, Juan Su, Anning Yin, Xinsheng Gao, Wei Wang, Jiao Li, Jian Kang, Jing Wang, Qian Zhou, Jing An, Zhishun Tang, Xinxin Wang, Huipeng Wan, Wei Chen, Pengbo Wu, Ping An |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-025-09802-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Osteonecrosis of the jaw associated with ustekinumab in the treatment of Crohn's disease
by: Jean Massaad, et al.
Published: (2024-10-01) -
Machine learning gene expression predicting model for ustekinumab response in patients with Crohn's disease
by: Manrong He, et al.
Published: (2021-12-01) -
Ustekinumab and Vedolizumab Dual Biologic Therapy in the Treatment of Crohn’s Disease
by: Eddie Y. Liu, et al.
Published: (2017-01-01) -
Monthly intravenous maintenance treatment with ustekinumab regains clinical response in patients with Crohn’s disease who no longer respond to the drug when administered subcutaneously
by: Berta López-Sáez, et al.
Published: (2025-07-01) -
Ustekinumab in the Treatment of Crohn’s Disease—A Narrative Review on Clinical Efficacy and Safety Profile
by: Dawid Piecuch, et al.
Published: (2025-05-01)